Sock Ngee Chong, Founder & CEO, Healthvantage
Today, Malaysia serves as a regional hub for pharmaceutical manufacturing and medical device production, catering to both domestic and international markets. The industry is currently undergoing transformation, driven by digital health innovations, biotechnology advancements, and a rising demand for high-quality healthcare solutions. Key players contributing to Malaysia’s pharmaceutical and life sciences landscape include both multinational corporations and homegrown enterprises.
Driving forward initiatives in R&D, manufacturing excellence, and healthcare accessibility is Sock Ngee Chong, the CEO of AesD International (M) and Founder and CEO of HEALTHVANTAGE , a company she has led since 2012.
Malaysia's Pharma Industry is Taking Off
By: Sujith Vasudevan, Managing Editor
It’s no secret that Malaysia is a major global exporter of pharmaceuticals. Last year, the country exported $471 million worth of pharma products, encompassing both generic and over-the-counter medicines.
Key Elements to Consider While Building Future-Ready Finance Teams
By: Mac Weaver, SVP and GM APAC, BlackLine
The world is swiftly transforming to become more digitally oriented, particularly within the finance sector. Traditional financial institutions
By: Ed Anuff, Chief Product Officer, DataStax
Generative AI is no longer just a futuristic concept; it is transforming how businesses innovate and interact with customers. With its potential to drive operational efficiency
By: Benjamin Boesch, Chief Digital Officer, VFS Global
The world is on the move again. After months of closures, the revival of various sectors is evident reopening of universities, hybrid working models, and high profile international events are back
By: Bancha Yathip, Founder and CEO, 89 Plus Energy Company Limited
The impact of renewable energy on economic advancement and carbon emissions has long emerged as a critical global issue.
By: Charmaine R A, CISO, Aboitiz Equity Venture Inc
In today’s digital age, cyber security is not just a priority for large corporations but also for small and medium-sized businesses (SMBs).
Top 10 CEOs from Pharma & Life Sciences Industry in Malaysia - 2025
CEOs also have a role in skills development, nurturing and educating talent individually and collectively. Even though their vision is about the positive development of the organisation, it also influences their public health and global health priorities, enhancing the knowledge around access to medicines and healthcare. To summarise, a common thread among CEOs in Malaysia's Pharma and Life Sciences industry is that they are pivotal in the evolution of the profession's global competitiveness; they do this by harnessing technology and generating healthier futures.
CEOs are often at the forefront of the adoption of new technologies like digital platforms, data analytics, and AI that change the practice of clinical procedures and the care that patients receive. These practices can positively impact drug development, clinical trials, and improve outcomes for patients. Through their leadership, they enable the transition of scientific discovery to commercialization so that organizations can adapt to the constantly evolving health landscape. They also promote sustainability and partner with the research community, governmental agencies, and global organizations. Their approach creates momentum and innovation across a variety of fields, including personalized medicine, vaccine development, and other diagnostic tools. Not only do they stimulate the use of digital adoption and automation, but they also create efficiencies that lead to productivity, which is balanced with compliance with regulatory practices.
CEOs play a role in developing skills, mentoring, and educating talent individually and collectively. While there is a focus on the positive evolution of the organization, it also influences their public health and global health priorities, expanding the understanding of access to medicines and health care. To summarise, a common theme across CEOs in the pharma and life sciences in Malaysia is their role of being responsible for the evolution of the profession's competitiveness in the global marketplace; they do so by leveraging technology and creating a healthier legacy.
CEO Insights Asia in this issue presents a list of ‘Top 10 CEOs from Pharma & Life Sciences Industry in Malaysia - 2025' who have leveraged their extensive industry expertise and experience in offering effective skills to the market. The following list has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable knowledge.
| Company Logo | Company Management | Company Name | Company Description | 
|---|---|---|---|
|  | Dr. Ahmad Adzuan Bin Abdul Rahman, Group CEO | TMC Life Sciences | A healthcare leader and entrepreneur with over 20 years of experience in clinical practice, hospital management, and corporate strategy | 
|  | Boowie Khoo, CEO | Nova Pharma Solutions | He has been in the pharmaceutical industry for more than 15 years, including 9.5 years with a pharmaceutical manufacturing plant, working on processes, equipment, and facilities engineering | 
|  | Joel W, Founder & CEO | Medhini Group | With a background in medical laboratory technology and biotechnology, he has experience in engineering and industrial projects | 
|  | Kean Ping Lim, CEO | Pharm-D Health Science | He has experience in healthcare management and business optimization, and under his leadership, the firm focuses on strategic partnerships and initiatives that enhance access to healthcare and more | 
|  | Kh Ng (Alan), Founder & CEO | Bounty Biotech | With nearly 30 years of experience in the livestock and biotechnology industry, his career spans the entire value chain, from animal feed and premix production to farming, processing, and retail | 
|  | Mohd Zul Efendi Hassan, CEO | Activ Pharma Malaysia | He has a history of working in the pharmaceutical industry and is skilled in medical devices, market research, regulatory requirements, healthcare, and regulatory affairs | 
|  | Parbodh Joshi, Group CEO | Healol Pharmaceuticals | He has been instrumental in expanding the company’s portfolio across pharmaceuticals, genetics, health supplements, and FMCG, while driving innovation and operational excellence | 
|  | Rahil Mahmood, CEO | Novugen Pharma | With over a decade of experience in the pharmaceutical industry, he has driven the company’s growth and innovation, focusing on complex and technology-intensive products | 
|  | Sock Ngee Chong, Founder & CEO | Healthvantage | With over two decades of experience in the pharmaceutical and medical devices sectors, she exemplifies leadership that blends scientific expertise with business acumen | 
|  | Wan Amir-Jeffery Bin Wan Abdul Majid, CEO | Duopharma Biotech | He has experience in the pharmaceutical industry, having held multiple senior leadership roles across strategy, operations, and commercial functions | 
Other Issues
We use cookies to ensure you get the best experience on our website. Read more...